| 1 |
NCT03981887 |
Not yet recruiting
New |
Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous Nafithromycin |
|
- Drug: Nafithromycin
- Other: Placebo
|
Interventional
|
Phase 1 |
- Wockhardt
- Clinartis, LLC
- Keystone Bioanalytical, Inc.
|
Industry / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Basic Science
|
- To assess safety
- To assess multiple dose drug tolerability
- To assess plasma PK parameters profile
|
10 |
All |
18 Years to 55 Years (Adult) |
NCT03981887 |
W-4873-105 |
|
June 17, 2019 |
June 22, 2019 |
August 30, 2019 |
June 11, 2019 |
June 11, 2019 |
|
- Spaulding Clinical Research
West Bend, Wisconsin, United States
|
|
| 2 |
NCT03980067 |
Recruiting
New |
Impact of Pre-Sedation Virtual Reality Game on Post-Discharge Negative Behaviors in the Pediatric Emergency Department |
|
- Other: Virtual Reality Game
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Supportive Care
|
- Post-Hospitalization Behavior Questionnaire (PHBQ)
- Modified Yale Preoperative Anxiety Scale (m-YPAS)
|
243 |
All |
6 Years to 17 Years (Child) |
NCT03980067 |
1300058-5 |
|
May 17, 2019 |
May 17, 2021 |
May 17, 2021 |
June 10, 2019 |
June 19, 2019 |
|
- Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 3 |
NCT03978455 |
Not yet recruiting
New |
A Pilot Study of the Learn, Connect, and Quit Mobile Application |
|
- Behavioral: Learn, Connect, and Quit Mobile Application
|
Observational
|
|
- University of Wisconsin, Madison
- National Cancer Institute (NCI)
- University of Wisconsin Center for Tobacco Research and Intervention
|
Other / NIH |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- Total time spent watching videos
- Clinical Utility of the Learn, Connect, and Quit Mobile Application
|
150 |
All |
18 Years and older (Adult, Older Adult) |
NCT03978455 |
2019-0274
R35CA197573 |
|
June 10, 2019 |
June 2020 |
June 2020 |
June 7, 2019 |
June 18, 2019 |
|
- University of Wisconsin Center for Tobacco Research and Intervention
Madison, Wisconsin, United States
|
|
| 4 |
NCT03976414 |
Recruiting
New |
Mind Over Matter: Electronic Bladder and Bowel Continence Self-management Program |
- Incontinence, Urinary
- Incontinence Bowel
|
|
Observational
|
|
- University of Wisconsin, Madison
|
Other |
- Observational Model: Ecologic or Community
- Time Perspective: Prospective
|
- Response on global perception of improvement (GPI) tool at 4 months
- Change in the response of Global patient satisfaction question (PSQ)
- Change in patient estimated percent improvement (EPI)
- (and 9 more...)
|
800 |
Female |
18 Years to 100 Years (Adult, Older Adult) |
NCT03976414 |
2018-1147 |
|
June 1, 2019 |
November 1, 2019 |
May 31, 2020 |
June 6, 2019 |
June 18, 2019 |
|
- University of Wisconsin-Madison School of Medicine and Public Health
Madison, Wisconsin, United States
|
|
| 5 |
NCT03972930 |
Recruiting
New |
Stereotactic Body Radiotherapy for Soft Tissue Sarcomas |
|
- Radiation: Stereotactic Body Radiotherapy
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Proportion of Participants with 2-year Local Control
- Proportion of Participants with 2-year Local Control: Primary Site vs Metastatic Site
- Proportion of Participants with 5-year Local Control: Primary Site vs Metastatic Site
- (and 5 more...)
|
48 |
All |
18 Years and older (Adult, Older Adult) |
NCT03972930 |
UW18149
2019-0360 |
|
July 1, 2019 |
July 1, 2023 |
July 1, 2026 |
June 4, 2019 |
June 11, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 6 |
NCT03971591 |
Recruiting
New |
Men Moving Forward: A Lifestyle Program for African-American Prostate Cancer Survivors |
|
- Behavioral: Guided Lifestyle Program Intervention
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
- Loyola University Chicago
- Marquette University
- University of Illinois at Chicago
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Change in body composition
- Increase in intake of fruits and vegetables
- Decrease of intake of red meat/processed meat
- (and 25 more...)
|
200 |
Male |
18 Years and older (Adult, Older Adult) |
NCT03971591 |
PRO00031416 |
MMF |
June 1, 2019 |
June 30, 2022 |
June 30, 2023 |
June 3, 2019 |
June 3, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 7 |
NCT03960580 |
Recruiting
New |
Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Sinusitis Without the Presence of Nasal Polyps |
|
|
Interventional
|
Phase 3 |
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Change from baseline in symptoms as measured by a composite score for each symptom of nasal congestion, facial pain or pressure sensation, and nasal discharge (anterior and/or posterior) at the end of Week 4
- Change from baseline to Week 24/Early Termination (ET) in the average percent of the volume opacified in the ethmoid and maxillary sinuses
- Change in Sinonasal Outcome Test 22 (SNOT-22) Total Score
- (and 24 more...)
|
399 |
All |
18 Years and older (Adult, Older Adult) |
NCT03960580 |
OPN-FLU-CS-3206 |
|
May 1, 2019 |
April 2021 |
June 2021 |
May 23, 2019 |
May 23, 2019 |
|
- Allergy, Asthma & Sinus Center, SC
Greenfield, Wisconsin, United States
|
|
| 8 |
NCT03960502 |
Recruiting
New |
A Safety and Pharmacokinetic Study of AG-881 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C] AG-881 and Concomitant Intravenous Microdose of [13C315N3] AG-881 |
- Healthy Male Participants
|
- Drug: AG-881
- Drug: [13C315N3]AG-881
|
Interventional
|
Phase 1 |
- Agios Pharmaceuticals, Inc.
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Amount of AG-881 Excreted in Urine (Aeu)
- Cumulative Aeu (Cum Aeu) of AG-881
- Percentage of AG-881 excreted in Urine and Feces (feu and fef, Respectively)
- (and 26 more...)
|
8 |
Male |
18 Years to 55 Years (Adult) |
NCT03960502 |
AG881-C-005 |
|
May 16, 2019 |
August 22, 2019 |
August 22, 2019 |
May 23, 2019 |
May 23, 2019 |
|
- Covance Clinical Research Unit Inc.
Madison, Wisconsin, United States
|
|
| 9 |
NCT03959163 |
Recruiting
New |
The Validity of the Quick Renal MRI in Pediatric Kidney Disease |
- Pyelonephritis
- Pyelonephritis Acute
- Renal Sclerosis
|
- Diagnostic Test: Quick MRI
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Sensitivity of Quick MRI as Compared to DMSA scan in Diagnosis of Suspected Acute Pyelonephritis
- Sensitivity of Quick MRI as compared to DMSA scan in Diagnosis of Renal Scars
- Specificity of Quick MRI as compared to DMSA scan in Diagnosis of Renal Scars
|
100 |
All |
up to 21 Years (Child, Adult) |
NCT03959163 |
2018-0492 |
|
May 7, 2019 |
May 2023 |
May 2023 |
May 22, 2019 |
May 22, 2019 |
|
- American Family Children's Hospital
Madison, Wisconsin, United States
|
|
| 10 |
NCT03958383 |
Not yet recruiting
New |
IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma |
|
- Biological: hu14.18-IL2
- Radiation: Radiation Therapy
- Biological: Nivolumab
- Biological: Ipilimumab
|
Interventional
|
Phase 1
Phase 2 |
- University of Wisconsin, Madison
- National Cancer Institute (NCI)
- Bristol-Myers Squibb
- (and 2 more...)
|
Other / NIH / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Incidence of Adverse Events
- Maximum Tolerated Dose (MTD)
- Maximum Administered Dose (MAD)
- (and 19 more...)
|
61 |
All |
18 Years and older (Adult, Older Adult) |
NCT03958383 |
UW16134
P30CA014520
2017-1464
R35CA197078 |
|
July 1, 2019 |
July 15, 2024 |
July 15, 2025 |
May 22, 2019 |
May 22, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 11 |
NCT03958214 |
Recruiting
New |
Promoting Self-Regulation Skills and Healthy Eating Habits in Early Head Start |
|
- Behavioral: Recipe 4 Success
- Behavioral: Usual practice Early Head Start
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Penn State University
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Prevention
|
- Change in children's healthy eating habits: Body mass index
- Change in children's healthy eating habits: Food diaries
- Change in children's healthy eating habits: Parent reports
- (and 6 more...)
|
240 |
All |
2 Years to 3 Years (Child) |
NCT03958214 |
2016-0465 |
|
November 8, 2015 |
December 31, 2019 |
December 31, 2019 |
May 21, 2019 |
May 21, 2019 |
|
- University of Wisconsin-Madison
Madison, Wisconsin, United States
|
|
| 12 |
NCT03958123 |
Completed
New |
Evaluation of the Effects of Multiple Doses of Cebranopadol on the Electrical Activity of the Heart in Healthy Subjects |
- Prolonged QTc Interval
- Pharmacokinetic
|
- Drug: 100 μg cebranopadol
- Drug: 200 μg cebranopadol
- Drug: 400 μg cebranopadol
- (and 3 more...)
|
Interventional
|
Phase 1 |
- Grünenthal GmbH
- Forest Laboratories
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- QTcNi change from time-matched baseline measurement on Day -1 to Day 29 - supported sitting position
- QTcNi change from time-matched baseline measurement on Day -1 to Day 29 - supine position
- QTcF change from time-matched baseline measurement on Day -1 to Day 29 - sitting position
- (and 38 more...)
|
171 |
All |
18 Years to 45 Years (Adult) |
NCT03958123 |
GRT-PK-12 |
|
July 10, 2013 |
November 27, 2013 |
November 27, 2013 |
May 21, 2019 |
May 23, 2019 |
|
- US001 Contract research organization
West Bend, Wisconsin, United States
|
|
| 13 |
NCT03950414 |
Not yet recruiting |
A Dose-Escalation Study Evaluating Safety and Tolerability of Viral-Specific T Cells Against CMV in Adult Kidney Transplant Recipients |
- Cytomegalovirus Infections
- Kidney Transplant Infection
|
- Biological: CMV specific T-cells
|
Interventional
|
Phase 1 |
- University of Wisconsin, Madison
- University of Wisconsin Program for Advanced Cell Therapy (PACT)
- University of Wisconsin School of Medicine and Public Health (UWSMPH)
- UW Health
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Safety and Tolerability:Time of Occurence of Acute GVHD
- Safety and Tolerability: Number of infusion-related adverse events
- Incidence of acute infusion-related toxicity
- (and 14 more...)
|
20 |
All |
18 Years to 75 Years (Adult, Older Adult) |
NCT03950414 |
2019-0060
PACT VST-C-002 |
|
June 2019 |
June 2023 |
June 2023 |
May 15, 2019 |
May 15, 2019 |
|
- University of Wisconsin School of Medicine and Public Health
Madison, Wisconsin, United States
|
|
| 14 |
NCT03949140 |
Recruiting |
Laser Hair Removal for Treatment of Pilonidal Disease |
|
- Procedure: Laser hair removal
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Incidence of disease-free remission
- Disease recurrence rate among subjects who subsequently require surgical intervention.
- Characterization of the degree of intervention required to obtain positive results.
- (and 4 more...)
|
20 |
All |
13 Years to 35 Years (Child, Adult) |
NCT03949140 |
2018-1031 |
|
February 18, 2019 |
February 2020 |
September 2021 |
May 14, 2019 |
May 14, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 15 |
NCT03943901 |
Not yet recruiting |
Split-Dose R-CHOP for Older Adults With DLBCL |
- Diffuse Large B Cell Lymphoma
- DLBCL
- Cancer
|
- Drug: Rituximab
- Drug: Cyclophosphamide
- Drug: Doxorubicin
- (and 3 more...)
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
- Medical College of Wisconsin
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Complete Response Rate (CR)
- Progression Free Survival (PFS)
- Overall Survival (OS)
- (and 2 more...)
|
46 |
All |
70 Years and older (Older Adult) |
NCT03943901 |
UW18131
2019-0138
SMPHMEDICINEHEM-ONC
A534260 |
|
June 20, 2019 |
June 20, 2021 |
June 20, 2022 |
May 9, 2019 |
June 4, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 16 |
NCT03940157 |
Not yet recruiting |
Faith and Community in Action: Increasing Awareness and Management of Depression in African American Communities |
- Depression
- Awareness
- Self-management
|
- Behavioral: Oh Happy Day Class - Still I Rise
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Urban League of Greater Madison
- African American Council of Churches Madison
- (and 2 more...)
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Patient Health Questionnaire-9 (PhQ-9)
|
100 |
All |
25 Years to 75 Years (Adult, Older Adult) |
NCT03940157 |
2019-0129 |
|
June 1, 2019 |
December 31, 2019 |
June 30, 2020 |
May 7, 2019 |
May 9, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 17 |
NCT03936478 |
Suspended |
Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast Cancer |
|
- Radiation: MRIdian Radiation Treatment Unit
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Physician Reported Cosmesis: 1-year
- Participant Quality of Life: BCTOS Survey
- Participant Quality of Life: Convenience of Care Scale
- (and 9 more...)
|
30 |
Female |
40 Years and older (Adult, Older Adult) |
NCT03936478 |
UW18099
2019-0322
SMPHHUMAN ONCOHUMAN ONCO
A533300 |
MAPBI |
July 2, 2019 |
July 1, 2022 |
July 1, 2026 |
May 3, 2019 |
June 12, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 18 |
NCT03935880 |
Recruiting |
Surgical Treatment for Great Toe Arthritis |
|
- Device: Cartiva Implant
- Procedure: Cheilectomy
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in foot and ankle ability : Assessment by Foot and Ankle Ability Measure (FAAM) Questionnaire
- Change in patient health : Assessment by 36-Item Short Form Survey (SF-36) Questionnaire
|
120 |
All |
18 Years to 88 Years (Adult, Older Adult) |
NCT03935880 |
2018-1546 |
|
April 15, 2019 |
April 2022 |
April 2022 |
May 2, 2019 |
May 2, 2019 |
|
- UW Health
Madison, Wisconsin, United States
|
|
| 19 |
NCT03935516 |
Enrolling by invitation |
Extended vs Flexed Elbow Casting |
|
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Alignment
- Complication Rate
- Range of Motion
- Caregiver Satisfaction Scores
|
176 |
All |
up to 18 Years (Child, Adult) |
NCT03935516 |
2017-1056
SMPHORTHOPEDIC&REHABORTHO
A536110 |
|
December 19, 2017 |
June 30, 2020 |
June 30, 2020 |
May 2, 2019 |
May 2, 2019 |
|
- American Family Children's Hospital
Madison, Wisconsin, United States
|
|
| 20 |
NCT03933813 |
Recruiting |
Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients |
- Epithelial Ovarian Cancer
- Anemia
- Iron Deficiency Anemia
|
|
Interventional
|
Phase 1
Phase 2 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Rate of Peri-operative Blood Transfusion
- Rate of Iron Deficiency Anemia
- Rate of Resolution of Iron Deficiency Anemia After Intervention
- Incidence of Treatment Emergent Adverse Events (AEs)
|
40 |
Female |
18 Years and older (Adult, Older Adult) |
NCT03933813 |
UW18106
2019-0022 |
|
June 15, 2019 |
January 2020 |
January 2020 |
May 1, 2019 |
June 5, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 21 |
NCT03931590 |
Recruiting |
A Human AME Study for Omaveloxolone |
|
- Drug: [14C]-Omaveloxolone
|
Interventional
|
Phase 1 |
- Reata Pharmaceuticals, Inc.
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Maximum concentration (Cmax) of omaveloxolone
- Area under the omaveloxolone concentration-time curve (AUC)
- Maximum concentration of total radioactivity in blood and plasma
- (and 3 more...)
|
8 |
Male |
18 Years to 55 Years (Adult) |
NCT03931590 |
408-C-1805 |
|
April 11, 2019 |
December 2019 |
December 2019 |
April 30, 2019 |
April 30, 2019 |
|
- Covance Clinical Research Unit (CRU) Inc.
Madison, Wisconsin, United States
|
|
| 22 |
NCT03931330 |
Recruiting |
Does Improving Vagal Tone Increase Mitochondrial Bioenergetics |
- Functional Gastrointestinal Disorders
- Irritable Bowel Syndrome
- Dyspepsia
- Functional Abdominal Pain Syndrome
|
- Device: Percutaneous neurostimulation
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Mitochondrial Bioenergetics
- Heart Rate Variability
- Functional Disability Inventory
|
7 |
All |
12 Years to 18 Years (Child, Adult) |
NCT03931330 |
1101710 |
|
October 10, 2017 |
September 2019 |
September 2020 |
April 30, 2019 |
April 30, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 23 |
NCT03922139 |
Recruiting |
Botox for the Treatment of Chronic Exertional Compartment Syndrome |
- Compartment Syndrome of Leg
|
- Drug: OnabotulinumtoxinA Injection
|
Interventional
|
Phase 1
Phase 2 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Decrease in pain as assessed by change in Sliding pain scale
|
12 |
All |
18 Years and older (Adult, Older Adult) |
NCT03922139 |
2017-1061 |
|
June 2019 |
March 2021 |
March 2021 |
April 19, 2019 |
June 7, 2019 |
|
- Pain Management Clinic
Madison, Wisconsin, United States
|
|
| 24 |
NCT03921255 |
Recruiting |
Cognitive Bias Modification for Thought-Action Fusion |
- Obsessive-Compulsive Disorder
|
- Other: Cognitive Bias Modification
|
Interventional
|
Not Applicable |
- University of Wisconsin, Milwaukee
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Change in Thought-Action Fusion Scale (TAFS) across Pre-training, Post-training, and 1-Month follow-up
- Change in Primary Obsession Evaluation of TAF Scale (POETS) across Pre-training, Post-training, and 1-Month follow-up
- Change in Revised Obsessional Intrusions Inventory - Distress (ROII-Distress) across Pre-training, Post-training, and 1-Month follow-up
|
66 |
All |
18 Years and older (Adult, Older Adult) |
NCT03921255 |
TAF Extended |
TAF |
April 10, 2016 |
August 31, 2019 |
August 31, 2019 |
April 19, 2019 |
April 19, 2019 |
|
- UWM Anxiety Disorders Laboratory
Milwaukee, Wisconsin, United States
|
|
| 25 |
NCT03919669 |
Enrolling by invitation |
A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking |
- Alzheimer Disease
- Mild Cognitive Impairment
|
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
- Cerveau Technologies, Inc.
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Change in [18F]MK-6240 uptake
- Correlate the changes in [18F]MK-6240 uptake and changes in clinical cognitive assessments by Mini-Mental Status Exam (MMSE)
- Correlate the changes in [18F]MK-6240 uptake and changes in clinical cognitive assessments by Clinical Dementia Rating Scale (CDR).
- (and 2 more...)
|
42 |
All |
50 Years to 85 Years (Adult, Older Adult) |
NCT03919669 |
2018-1348 |
|
April 1, 2019 |
January 2022 |
September 2022 |
April 18, 2019 |
May 24, 2019 |
|
- University of Wisconsin-Madison
Madison, Wisconsin, United States
|
|
| 26 |
NCT03913468 |
Active, not recruiting |
Outcomes of Septic Shock Patients Treated With a Metabolic Resuscitation Bundle Consisting of Intravenous Hydrocortisone, Ascorbic Acid and Thiamine. |
- Septic Shock
- Ascorbic Acid Deficiency
|
- Drug: Intravenous Ascorbic Acid
|
Observational
|
|
- University of Wisconsin, Madison
|
Other |
- Observational Model: Cohort
- Time Perspective: Retrospective
|
- Duration of Vasopressors
- ICU mortality
- Need for Renal Replacement Therapy
|
80 |
All |
18 Years to 90 Years (Adult, Older Adult) |
NCT03913468 |
2018-1310 |
|
January 1, 2019 |
September 1, 2019 |
September 1, 2019 |
April 12, 2019 |
May 23, 2019 |
|
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
|
|
| 27 |
NCT03911973 |
Not yet recruiting |
Gedatolisib Plus Talazoparib in Advanced Triple Negative or BRCA1/2 Positive, HER2 Negative Breast Cancers |
- TNBC - Triple-Negative Breast Cancer
|
- Drug: Gedatolisib
- Drug: Talazoparib
|
Interventional
|
Phase 1
Phase 2 |
- Kari Wisinski
- Pfizer
- Big Ten Cancer Research Consortium
|
Other / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Maximum Tolerated Dose (MTD) of talazoparib in combination with gedatolisib (Phase I)
- Objective Response Rate (ORR) (Phase II)
- Investigator-assessed Progression-Free Survival (PFS) (Cohort B only)
- (and 5 more...)
|
54 |
All |
18 Years and older (Adult, Older Adult) |
NCT03911973 |
BTCRC-BRE18-337 |
|
May 2019 |
May 2021 |
May 2022 |
April 11, 2019 |
April 11, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 28 |
NCT03911609 |
Recruiting |
Cardiovascular Autonomic Function and Endogenous Pain Modulation |
- Fibromyalgia
- Exercise
- Pain
- (and 2 more...)
|
- Other: Exercise
- Other: Cognitive Task
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Change from Baseline Pressure Pain Threshold to immediately after performance of exercise.
- Change from Baseline Pressure Pain Threshold to immediately after cognitive task.
- Change from Baseline Pressure Pain Threshold to during the submersion of the foot in ice water.
- (and 18 more...)
|
250 |
All |
18 Years to 75 Years (Adult, Older Adult) |
NCT03911609 |
HR-1812027243 |
|
March 20, 2019 |
December 30, 2022 |
December 30, 2022 |
April 11, 2019 |
April 11, 2019 |
|
- Marquette University
Milwaukee, Wisconsin, United States
|
|
| 29 |
NCT03891797 |
Active, not recruiting |
PTSD Treatment for Incarcerated Men and Women |
|
- Other: Cognitive Processing Therapy
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- PTSD-Checklist-5 (PCL-5)
- Eligibility
- Participation
- (and 8 more...)
|
100 |
All |
18 Years to 55 Years (Adult) |
NCT03891797 |
2018-0630 |
|
March 5, 2019 |
September 15, 2019 |
December 25, 2019 |
March 27, 2019 |
June 5, 2019 |
|
- Fox Lake Correctional Institute
Fox Lake, Wisconsin, United States
|
|
| 30 |
NCT03889522 |
Recruiting |
The Influence of Non-Caloric Artificial Sweeteners on Youth With Type 1 Diabetes |
|
- Diagnostic Test: Bioelectrical Impedance Analysis
- Diagnostic Test: Total Body Dual-energy X-ray Absorptiometry
- Diagnostic Test: Blood draw
|
Observational
|
|
- Medical College of Wisconsin
|
Other |
- Observational Model: Cohort
- Time Perspective: Cross-Sectional
|
- Quantify artificial sweetener consumption in youth with type 1 diabetes
- Examine the relationship between artificial sweeteners and body composition
- Examine the relationship between artificial sweeteners and kidney function
- (and 5 more...)
|
30 |
All |
5 Years to 17 Years (Child) |
NCT03889522 |
1351723 |
|
May 1, 2019 |
May 1, 2020 |
May 1, 2020 |
March 26, 2019 |
June 7, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 31 |
NCT03888040 |
Enrolling by invitation |
Fatigability of Lower Limb Muscle in Older Adults: Protective Effects of Strength Training Exercise in Old Men and Women |
|
|
Interventional
|
Not Applicable |
- Marquette University
- National Institute on Aging (NIA)
- Ball State University
- Medical College of Wisconsin
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Changes in 1 RM (One Repetition Maximum) after 8 weeks resistance training
- Changes in Maximum voluntary contraction (MVC) force after 8 weeks resistance training
- Changes in Knee Extensor Power Curve after 8 weeks resistance training
- (and 17 more...)
|
182 |
All |
18 Years and older (Adult, Older Adult) |
NCT03888040 |
HR-2945
R01AG048262 |
|
April 22, 2015 |
December 31, 2021 |
December 31, 2021 |
March 25, 2019 |
March 25, 2019 |
|
- Sandra K. Hunter
Milwaukee, Wisconsin, United States
|
|
| 32 |
NCT03887572 |
Recruiting |
Adaption of Mobilizing Older Adult Patients Via a Systems-based Intervention for a Non-Academic Hospital |
- Early Mobility
- Older Adults
- Hospital Acquired Condition
|
|
Observational
|
|
- University of Wisconsin, Madison
- University of Wisconsin Institute for Clinical and Translational Research
- Aurora Health Care
|
Other |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- Change in gait speed
- Change in Self-report on Katz Activity of Daily Living (ADL) Index
- Change in Life Space Assessment
- (and 16 more...)
|
40 |
All |
65 Years and older (Older Adult) |
NCT03887572 |
2018-1025 |
MOVIN |
March 4, 2019 |
December 31, 2019 |
March 31, 2020 |
March 25, 2019 |
March 25, 2019 |
|
- Aurora St. Luke's Medical Center
Milwaukee, Wisconsin, United States
|
|
| 33 |
NCT03881397 |
Recruiting |
Youth Health and Social Media |
- Sleep
- Physical Activity
- Family and Household
- (and 2 more...)
|
- Behavioral: Family Media Use Plan
- Behavioral: Media Use Resources Awareness
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Facebook, Inc.
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Technology and Media Use Rules
- Changes in sleep behavior
- Changes in risk for Problematic Internet Use
|
3000 |
All |
12 Years to 17 Years (Child) |
NCT03881397 |
2018-0787 |
|
April 4, 2019 |
December 2019 |
December 2020 |
March 19, 2019 |
April 29, 2019 |
|
- University of Wisconsin Madison
Madison, Wisconsin, United States
|
|
| 34 |
NCT03873129 |
Recruiting |
ART-CHESS: A Mobile Health Application to Support People Living With HIV and Addiction |
- HIV/AIDS
- Substance Use Disorders
|
- Behavioral: mobile health app (mHealth)
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Change in the Viral suppression among study semesters of A-CHESS use versus semesters of without A-CHESS use.
- Change in the Attendance at HIV Clinic Appointments among study semesters of A-CHESS use versus semesters of without A-CHESS use.
- Change in the Drug usage among study semesters of A-CHESS use versus semesters of without A-CHESS use.
- Change in the Medication adherence among study semesters of A-CHESS use versus semesters of without A-CHESS use.
|
360 |
All |
18 Years and older (Adult, Older Adult) |
NCT03873129 |
2016-1190 |
|
May 2016 |
March 2021 |
March 2021 |
March 13, 2019 |
March 13, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 35 |
NCT03871504 |
Recruiting |
The Influence of Baseline Sensitivity and Expectation on Exercise-induced Hypoalgesia in Young Healthy Adults |
|
- Other: Submaximal isometric exercise
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- The change from baseline of pain ratings during temporal summation of pressure pain assessment
- Expectation
- State version of the State-Trait Anxiety Inventory (STAI)
- (and 6 more...)
|
250 |
All |
18 Years and older (Adult, Older Adult) |
NCT03871504 |
HR-2999 |
|
November 25, 2017 |
December 30, 2022 |
December 30, 2022 |
March 12, 2019 |
March 12, 2019 |
|
- Marquette University
Milwaukee, Wisconsin, United States
|
|
| 36 |
NCT03864926 |
Recruiting |
Envarsus in Delayed Graft Function (E-DGF) |
|
- Drug: Envarsus XR
- Drug: Tacrolimus
|
Interventional
|
Phase 4 |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Number of days needed to recover from delayed graft function (DGF)
- Number of Tacrolimus or Envarsus XR Dose Adjustments Required During the Period of DGF.
|
100 |
All |
18 Years and older (Adult, Older Adult) |
NCT03864926 |
2018-0530 |
E-DGF |
March 18, 2019 |
February 2021 |
August 2021 |
March 6, 2019 |
April 4, 2019 |
|
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
|
|
| 37 |
NCT03864601 |
Recruiting |
A Study of (14C) Radiolabeled JNJ-56136379 in Healthy Male Participants |
|
|
Interventional
|
Phase 1 |
- Janssen Research & Development, LLC
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Cmax: Ratio of JNJ-56136379 Concentration and Total Radioactivity in Plasma
- AUC(0-last): Ratio of JNJ-56136379 Concentration and Total Radioactivity in Plasma
- AUC(0-infinity): Ratio of JNJ-56136379 Concentration and Total Radioactivity in Plasma
- (and 17 more...)
|
6 |
Male |
18 Years to 55 Years (Adult) |
NCT03864601 |
CR108586
56136379HPB1007 |
|
April 9, 2019 |
May 31, 2019 |
July 1, 2019 |
March 6, 2019 |
April 30, 2019 |
|
- Covance Clinical Research Unit
Madison, Wisconsin, United States
|
|
| 38 |
NCT03863509 |
Recruiting |
E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease |
- Tobacco Use
- E-Cigarette Use
- Cardiovascular Diseases
- Pulmonary Disease
|
- Behavioral: Cigarettes
- Behavioral: E-Cigarettes
|
Observational
|
|
- University of Wisconsin, Madison
- National Institutes of Health (NIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Wisconsin Center for Tobacco Research and Intervention
|
Other / NIH |
- Observational Model: Case-Control
- Time Perspective: Prospective
|
- Brachial Artery Flow-Mediated Dilation (FMD)
- Forced Expiratory Volume (FEV1)
- Carotid Intima-Media Thickness (IMT)
- (and 9 more...)
|
440 |
All |
18 Years and older (Adult, Older Adult) |
NCT03863509 |
2017-1090
1R01HL139331-01 |
|
March 5, 2019 |
April 30, 2022 |
December 30, 2022 |
March 5, 2019 |
March 28, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 39 |
NCT03856320 |
Recruiting |
Teaching Obesity Treatment Options to Adult Learners Trial |
- Obesity
- Patient Education
- Weight Loss
|
- Behavioral: Educational Video
|
Interventional
|
Not Applicable |
- VA Office of Research and Development
- The Clowes Fund, Inc.
|
U.S. Fed / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Health Services Research
|
|
40 |
All |
18 Years to 70 Years (Adult, Older Adult) |
NCT03856320 |
CDX 18-001 |
TOTAL |
May 13, 2019 |
May 13, 2020 |
June 30, 2023 |
February 27, 2019 |
May 15, 2019 |
|
- William S. Middleton Memorial Veterans Hospital, Madison, WI
Madison, Wisconsin, United States
|
|
| 40 |
NCT03853811 |
Recruiting |
Customized Orthosis for Children With Clubfoot |
- Congenital Talipes Equinovarus
|
- Device: Ankle Foot Orthosis (AFO)
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Assessment of Functional Outcomes of Bracing Treatment Using Dimeglio Scores
- Time Spent in Brace to Assess Brace Compliance
- Assessing Treatment Factors that Impact Brace Compliance with Parental Questionnaires
- Assessing Demographic Factors that Impact Brace Compliance with Parental Questionnaire
|
10 |
All |
up to 12 Months (Child) |
NCT03853811 |
1246407 |
|
April 17, 2019 |
March 1, 2020 |
March 1, 2020 |
February 26, 2019 |
April 30, 2019 |
|
- Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 41 |
NCT03853473 |
Recruiting |
Prehabilitation of Frail Surgical Cancer Patients Using Remote Ischemic Preconditioning |
- Colon Cancer
- Fragility
- Prehabilitaiton
- Surgery
|
- Procedure: Remote Ischemic Preconditioning
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- 6 Minute Walk Test Distance (Pre Surgery)
- 10 Meter Walk Test (Pre Surgery)
- Timed Up and Go (Pre Surgery)
- (and 6 more...)
|
96 |
All |
55 Years to 85 Years (Adult, Older Adult) |
NCT03853473 |
PRO00032510 |
Prehab |
February 22, 2019 |
February 21, 2022 |
February 21, 2022 |
February 25, 2019 |
February 25, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 42 |
NCT03848754 |
Recruiting |
Pracinostat in Combination With Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) |
|
- Drug: Gemtuzumab Ozogamicin
- Drug: Pracinostat
|
Interventional
|
Phase 1 |
- Medical College of Wisconsin
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Maximum-tolerated dose
- Overall Response
- Progression-Free Survival
- Overall Survival
|
18 |
All |
18 Years and older (Adult, Older Adult) |
NCT03848754 |
PRO 33922 |
|
May 24, 2019 |
May 2020 |
March 2021 |
February 21, 2019 |
June 10, 2019 |
|
- Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 43 |
NCT03848689 |
Enrolling by invitation |
FQ Restriction for the Prevention of CDI |
- Clostridium Difficile
- Clostridium Difficile Infection
- C Difficile Colitis
|
- Other: fluoroquinolone preprescription authorization
- Other: Control
|
Observational
|
|
- University of Wisconsin, Madison
- Agency for Healthcare Research and Quality (AHRQ)
|
Other / U.S. Fed |
- Observational Model: Other
- Time Perspective: Prospective
|
- Change in the number of Incidences of hospital-onset due to Clostridium difficile infection (CDI) before and after following FQ PPA strategy
- Change in the number of Incidences of healthcare-associated CDI before and after following FQ PPA strategy
- Change in the usage of FQ from the time of participant hospital admission per 1000 patient-days.
- (and 6 more...)
|
11000 |
All |
Child, Adult, Older Adult |
NCT03848689 |
2018-0852
1R01HS026226-01 |
FIRST |
January 1, 2018 |
February 28, 2023 |
June 30, 2023 |
February 21, 2019 |
February 21, 2019 |
|
- University of Wisconsin Hospital & Clinics
Madison, Wisconsin, United States
|
|
| 44 |
NCT03837392 |
Recruiting |
Efficacy of Brief Acceptance and Commitment Therapy (ACT) for Perinatal Depression |
- Post Partum Depression
- Perinatal Depression
- Post Partum Anxiety
- Perinatal Anxiety
|
- Diagnostic Test: Initial Screening at Enrollment (14-20 weeks pregnant)
- Diagnostic Test: Pregnancy Planning Visit
- Behavioral: Group Intervention: ACT Session
- (and 3 more...)
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- Change in Hamilton Depression and Rating Scale (HDRS) from Baseline
- Change in Hamilton Anxiety Rating Scale (HAM-A) from Baseline
- Change in Five Facet Mindfulness Questionnaire (FFMQ) from Baseline
- (and 16 more...)
|
80 |
Female |
18 Years to 45 Years (Adult) |
NCT03837392 |
2018-1165 |
|
February 18, 2019 |
February 15, 2021 |
February 15, 2021 |
February 12, 2019 |
February 19, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 45 |
NCT03824145 |
Active, not recruiting |
Every Day Counts: A Lifestyle Program for Women With Metastatic Breast Cancer |
|
- Behavioral: Lifestyle Intervention
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
- Loyola University Chicago
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Intervention adherence
- Intervention retention
- Change in Quality of Life
- (and 9 more...)
|
40 |
Female |
18 Years and older (Adult, Older Adult) |
NCT03824145 |
27600 |
EDC |
January 2, 2018 |
June 30, 2019 |
June 30, 2019 |
January 31, 2019 |
January 31, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 46 |
NCT03818295 |
Completed |
A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers |
|
|
Interventional
|
Phase 1 |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Amount of total radioactivity excreted in urine (Aeu) and feces (Aef)
- Cumulative Aeu and cumulative Aef
- Percentage of total radioactivity excreted in urine (feu) and feces (fef)
- (and 27 more...)
|
8 |
Male |
18 Years to 55 Years (Adult) |
NCT03818295 |
PRL-105 |
|
March 1, 2019 |
April 24, 2019 |
April 24, 2019 |
January 28, 2019 |
June 19, 2019 |
|
- Covance Clinical Research Unit Inc.
Madison, Wisconsin, United States
|
|
| 47 |
NCT03810235 |
Recruiting |
The OBstetric Lidocaine Patch (OBLido) Trial |
|
- Drug: Transdermal Lidocaine Patch
- Drug: Transdermal Hydrocolloid Placebo Patch
|
Interventional
|
Phase 4 |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Total dose of opioids received in the first 24 hours following Cesarean
- Post-operative pain score at 24 hours post-operatively
|
60 |
Female |
18 Years to 59 Years (Adult) |
NCT03810235 |
Meriter IRB 2018-015 |
OBLido |
February 15, 2019 |
December 31, 2019 |
March 31, 2020 |
January 18, 2019 |
February 19, 2019 |
|
- UnityPoint Health-Meriter Hospital
Madison, Wisconsin, United States
|
|
| 48 |
NCT03806283 |
Active, not recruiting |
Angiotensin 2 Receptor (AT2R) in Endothelial Cells in Preeclampsia |
- Pre-Eclampsia
- Vascular Diseases
|
- Procedure: Omental Biopsy
|
Observational
|
|
- University of Wisconsin, Madison
- National Heart, Lung, and Blood Institute (NHLBI)
|
Other / NIH |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Quantify the vascular AT2R expression and vascular function in placental and omental vascular arteries in both preeclamptic and controlled pregnancies.
- To test if ex-vivo treatment of AT2R agonists reverses the endothelial dysfunction and improves vasoconstriction in the preeclamptic vessels.
- To test AT2R mediated mechanisms on endothelial derived hyperpolarizing factor, nitric oxide and prostacyclin pathway of vascular relaxation to examine AT2's role in vaso-relaxation and AT2R mediated vasoconstrictor pathway will be defined.
|
70 |
Female |
18 Years to 35 Years (Adult) |
NCT03806283 |
Meriter IRB 2018-006
5R01HL134779-02 |
|
November 20, 2018 |
July 1, 2021 |
July 1, 2022 |
January 16, 2019 |
January 17, 2019 |
|
- UnityPoint Health-Meriter Hospital
Madison, Wisconsin, United States
|
|
| 49 |
NCT03805659 |
Not yet recruiting |
HDtDCS in Logopenic Variant PPA: Effects on Language and Neural Mechanisms |
- Primary Progressive Aphasia
|
- Device: HD-tDCS
- Device: Sham
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Language Performance on seven cognitive assessments: Picture Naming, Letter & Category Fluency, Digit Span Test, Phonological Short-term Memory Test, Word and non-word rhyme matching, Spontaneous Speech Sample, and Communicative Effectiveness Index.
- Brain Connectivity as seen on fMRI (functional MRI)
- Neuronal Frequencies and Synchronizations as seen on rsMEG (resting state MEG)
|
20 |
All |
45 Years and older (Adult, Older Adult) |
NCT03805659 |
32037 |
|
June 2019 |
May 2021 |
May 2021 |
January 16, 2019 |
January 16, 2019 |
|
- The Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 50 |
NCT03805529 |
Recruiting |
The Singing Heart Study |
- Impact of Singing
- Cardiovascular Health
- Cardiovascular Risk Factors
- Cardiovascular Diseases
|
|
Observational
|
|
- Medical College of Wisconsin
|
Other |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- The change in heart rate variability during singing
- The change from baseline vascular endothelial function in subjects who've participated in singing intervention
- The change in cardiac hemodynamics
- Asses subjects' self-assessment of perceived exertion during singing
|
70 |
All |
18 Years and older (Adult, Older Adult) |
NCT03805529 |
26191 |
|
February 22, 2018 |
July 31, 2019 |
August 1, 2019 |
January 15, 2019 |
April 24, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 51 |
NCT03801174 |
Recruiting |
Using Partners to Enhance Long-Term Weight Loss |
|
- Behavioral: Partner-assisted intervention
- Behavioral: Patient-only intervention
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- Duke University
- RTI International
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Body weight (kg)
- Caloric intake (kcal)
- Physical activity
|
460 |
All |
18 Years to 74 Years (Adult, Older Adult) |
NCT03801174 |
2018-1400 |
Partner2Lose |
January 15, 2019 |
January 1, 2023 |
January 1, 2023 |
January 11, 2019 |
March 28, 2019 |
|
- University of Wisconsin-Madison
Madison, Wisconsin, United States
|
|
| 52 |
NCT03799120 |
Enrolling by invitation |
Daily Versus Twice Per Day Tamsulosin for Ureteral Stent Symptoms |
|
- Drug: Tamsulosin BID
- Other: Placebo
|
Interventional
|
Phase 4 |
- Gundersen Lutheran Medical Foundation
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Outcomes Assessor)
- Primary Purpose: Supportive Care
|
- Ureteric Stent Symptoms Questionnaire
|
80 |
All |
18 Years to 70 Years (Adult, Older Adult) |
NCT03799120 |
2-18-11-001 |
|
February 18, 2019 |
December 2021 |
December 2021 |
January 10, 2019 |
February 25, 2019 |
|
- Gundersen Health System
La Crosse, Wisconsin, United States
|
|
| 53 |
NCT03798691 |
Recruiting |
Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab |
- Inflammatory Bowel Diseases
- Crohn Disease
- Ulcerative Colitis
- Herpes Zoster
|
|
Interventional
|
Phase 4 |
- University of Wisconsin, Madison
- Boston Medical Center
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Change in cell mediated immunity
- Percent of participants with sustained cell mediated immunity measured via ELISPOT after immunization.
- Percent of participants with a change in antibody concentration post immunization
- (and 3 more...)
|
30 |
All |
50 Years to 70 Years (Adult, Older Adult) |
NCT03798691 |
2018-1037 |
|
June 2019 |
April 1, 2020 |
January 1, 2021 |
January 10, 2019 |
May 16, 2019 |
|
- University of Wisconsin Digestive Health Center
Madison, Wisconsin, United States
|
|
| 54 |
NCT03798301 |
Recruiting |
Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells |
- CMV Infection
- Cytomegalovirus Infections
- CMV Viremia
- Opportunistic Infections
|
- Biological: CMV-specific T-cells
|
Interventional
|
Phase 1 |
- University of Wisconsin, Madison
- University of Wisconsin Program for Advanced Cell Therapy (PACT)
- University of Wisconsin Carbone Cancer Center (UWCCC)
- (and 2 more...)
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Feasibility: Number of Participants Who Drop-Out Before T-Cell Transfer
- Feasibility: Number of Days from Participant Enrollment to Administration of CMV-VST
- Feasibility: Number of Participants with Expansion of CMV-VST from Donors
- (and 9 more...)
|
20 |
All |
1 Month and older (Child, Adult, Older Adult) |
NCT03798301 |
UW18073
2018-1278
NCI-2019-00245 |
|
June 15, 2019 |
September 1, 2023 |
September 1, 2024 |
January 9, 2019 |
May 15, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 55 |
NCT03795519 |
Completed |
A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Olinciguat in Healthy Male Volunteers |
|
|
Interventional
|
Phase 1 |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Amount of total radioactivity excreted in urine (Aeu) and feces (Aef)
- Cumulative Aeu and cumulative Aef
- Percentage of total radioactivity excreted in urine (feu) and feces (fef)
- (and 27 more...)
|
8 |
Male |
18 Years to 55 Years (Adult) |
NCT03795519 |
OLI-103 |
|
January 17, 2019 |
February 27, 2019 |
February 27, 2019 |
January 7, 2019 |
April 3, 2019 |
|
- Covance Clinical Research Unit Inc.
Madison, Wisconsin, United States
|
|
| 56 |
NCT03794882 |
Recruiting |
Impact of Quadratus Lumborum Block on Recovery Profile After Ventral Hernia Repair |
- Pain, Postoperative
- Opioid Use
|
- Procedure: Quadratus Lumborum Block
- Procedure: Standard Medical Management
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Postoperative Day (POD) 1 Pain Score
- Pain Score at Rest
- Pain Score with Activity
- (and 10 more...)
|
48 |
All |
18 Years to 80 Years (Adult, Older Adult) |
NCT03794882 |
2018-0793 |
|
May 6, 2019 |
January 2021 |
February 2021 |
January 7, 2019 |
May 7, 2019 |
|
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
|
|
| 57 |
NCT03791476 |
Recruiting |
RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function |
|
- Drug: rhC1INH
- Other: Saline Solution
|
Interventional
|
Phase 1 |
- University of Wisconsin, Madison
- Pharming Technologies B.V.
|
Other / Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Treatment
|
- Number of patients that do not meet DGF criteria based on creatinine levels following kidney transplantation from DCD donor who are treated with study drug compared to placebo
- Incidence of adverse and serious adverse events will be assessed via descriptive statistics method
- Ascertain whether any unexpected toxicities will occur in this patient population according to the Common Toxicity Criteria for Adverse Events (CTCAE) patient population
- (and 6 more...)
|
20 |
All |
18 Years and older (Adult, Older Adult) |
NCT03791476 |
2017-1325 |
|
June 17, 2019 |
July 2020 |
December 2020 |
January 1, 2019 |
June 13, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 58 |
NCT03787134 |
Recruiting |
Oscillatory Contributions to Working Memory and Attention |
|
- Behavioral: working memory and attention
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Experiment 1.a. Behavioral accuracy
- Experiment 1.a. Reaction time
- Experiment 1.a. Changes in multivariate pattern classification of electroencephalography data in response to prioritization cues and in response to pulses of transcranial magnetic stimulation.
- (and 16 more...)
|
269 |
All |
18 Years to 35 Years (Adult) |
NCT03787134 |
2016-0500 |
|
March 1, 2019 |
December 2023 |
December 2023 |
December 25, 2018 |
April 24, 2019 |
|
- University of Wisconsin - Madison
Madison, Wisconsin, United States
|
|
| 59 |
NCT03785028 |
Not yet recruiting |
Analysis of Electrocorticographic Signals |
|
- Behavioral: working memory and attention
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Experiment 1.b. Prioritization cue-related changes in the neural representation of stimuli
- Experiment 1.b. Prioritization cue-related changes in phase-amplitude coupling
- Experiment 3.b. Covert spatial attention-related changes in phase-amplitude coupling
|
30 |
All |
18 Years to 65 Years (Adult, Older Adult) |
NCT03785028 |
2015-0282 |
|
June 2019 |
December 2023 |
December 2023 |
December 24, 2018 |
May 16, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 60 |
NCT03783897 |
Recruiting |
A Drug-drug Interaction Study to Investigate the Effect of Coadministration of EDP-305 on the PK of a Combined Oral Contraceptive in Healthy Female Subjects |
- NASH - Nonalcoholic Steatohepatitis
|
- Drug: EDP-305
- Drug: Oral Contraceptive
|
Interventional
|
Phase 1 |
- Enanta Pharmaceuticals
- Covance
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Area under the plasma concentration-time (AUC0-τ) curve for OC with and without coadministration with EDP-305
- Cmax for OC with and without coadministration with EDP-305
- Area under the plasma concentration-time (AUC0-τ) curve for EDP-305 when coadministration with OC
- (and 2 more...)
|
38 |
Female |
18 Years to 45 Years (Adult) |
NCT03783897 |
EDP 305-008 |
|
November 27, 2018 |
April 2019 |
April 2019 |
December 21, 2018 |
December 21, 2018 |
|
- Covance Clinical Research Unit
Madison, Wisconsin, United States
|
|
| 61 |
NCT03778476 |
Recruiting |
Isometric Exercise and Endogenous Pain Inhibition |
|
- Other: Isometric Exercise
|
Interventional
|
Not Applicable |
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Conditioned Pain Modulation
- Vibration Perception Threshold
|
60 |
All |
18 Years to 75 Years (Adult, Older Adult) |
NCT03778476 |
HR3035 |
|
May 25, 2018 |
August 2022 |
August 2022 |
December 18, 2018 |
December 18, 2018 |
|
- Marquette University
Milwaukee, Wisconsin, United States
|
|
| 62 |
NCT03778385 |
Recruiting |
Influence of Exercise Type, Pain Mechanisms, and Biopsychosocial Contributions to Pain Relief in Those With Fibromyalgia |
|
|
Interventional
|
Not Applicable |
- Marquette University
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Change from Baseline Short-Form McGill Pain Questionnaire to 3-days after performance of exercise.
- Change from Baseline Fibromyalgia Impact Questionnaire - Revised to 3-days after performance of exercise.
- Change from Baseline Pain Rating from a Pressure Pain Device to immediately after performance of exercise.
- (and 16 more...)
|
200 |
All |
18 Years to 75 Years (Adult, Older Adult) |
NCT03778385 |
HR-3035
R15HD090265 |
|
February 3, 2017 |
January 2022 |
January 2022 |
December 18, 2018 |
December 18, 2018 |
|
- Marquette University
Milwaukee, Wisconsin, United States
|
|
| 63 |
NCT03771001 |
Recruiting |
5Minutes4Myself: A Wellness Program for Caregivers |
- Autism
- Stress
- Autism Spectrum Disorder
|
- Other: Motivational Interviewing coaching and habit-building app
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- SF-36 Questionnaire
- Perceived Stress Scale
- Ryff's Psychological Well-Being Scale
- (and 4 more...)
|
70 |
All |
Child, Adult, Older Adult |
NCT03771001 |
2015-1004 |
|
November 2015 |
August 2021 |
December 2022 |
December 10, 2018 |
December 10, 2018 |
|
- Community Sites
Madison, Wisconsin, United States
|
|
| 64 |
NCT03769311 |
Recruiting |
Cetuximab in Head and Neck Cancer Patients |
- Head and Neck Cancer
- Squamous Cell Carcinoma
|
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
- National Cancer Institute (NCI)
- National Institute of Dental and Craniofacial Research (NIDCR)
|
Other / NIH |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in Tumor Size
- Objective Tumor Response Rate - AXL expression
- Rate of Hospital Re-admission for CTX-related Complications
|
36 |
All |
18 Years and older (Adult, Older Adult) |
NCT03769311 |
UW18098
P30CA014520
P50DE026787
NCI-2018-02990
2018-1232 |
|
May 8, 2019 |
March 2022 |
March 2023 |
December 7, 2018 |
May 15, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 65 |
NCT03769298 |
Recruiting |
CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients |
- Kidney Pancreas Transplantation
|
|
Interventional
|
Phase 2
Phase 3 |
- University of Wisconsin, Madison
- Veloxis Pharmaceuticals
|
Other / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in patient and physician-assessed degree of tremors based on Fahn-Tolosa-Marin Tremor Rating Scale
- Change in patient and physician-assessed degree of tremors based on Quality of Life in Essential Tremor (QUEST) Questionnaire
- Scores on Quality of Life in Essential Tremor Questionnaires
- (and 7 more...)
|
30 |
All |
18 Years to 70 Years (Adult, Older Adult) |
NCT03769298 |
2018-0821 |
|
February 27, 2019 |
October 31, 2022 |
October 31, 2022 |
December 7, 2018 |
March 5, 2019 |
|
- University of Wisconsin
Madison, Wisconsin, United States
|
|
| 66 |
NCT03766841 |
Enrolling by invitation |
Avoiding Health Disparities When Collecting Patient Contextual Data for Clinical Care and Pragmatic Research |
|
- Behavioral: Facilitated Enrollment
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Health Services Research
|
- Composite Communication Score As Assessed by Communication Assessment Tool, a validated 14-item patient-reported outcome.
- Change in the composite score of the patient activation measure, a validated instrument to assess a patient's engagement and activation in their health issues.
|
300 |
All |
18 Years and older (Adult, Older Adult) |
NCT03766841 |
PRO00031177 |
|
January 28, 2019 |
January 1, 2020 |
January 1, 2020 |
December 6, 2018 |
January 24, 2019 |
|
- Froedtert & Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 67 |
NCT03764943 |
Not yet recruiting |
Immunonutrition and Carbohydrate Loading Strategies in Breast Reconstruction |
- Wound Complication
- Wound Heal
- Complications Wound
- (and 4 more...)
|
- Dietary Supplement: Impact Advanced Recovery
- Dietary Supplement: Boost Breeze
|
Interventional
|
Phase 3 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Number of Incidents of Wound Complications 30-days Post-Op
- Number of Patients that Return to the Operating Room 30-days Post-Op
- Average Length of Hospitalization for Autologous Reconstruction Patients
- (and 2 more...)
|
132 |
Female |
18 Years and older (Adult, Older Adult) |
NCT03764943 |
UW18101
2018-1107 |
|
June 2019 |
January 1, 2021 |
April 1, 2021 |
December 5, 2018 |
May 17, 2019 |
|
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
|
|
| 68 |
NCT03758339 |
Completed |
A Study of the Absorption, Metabolism, and Excretion of Tucatinib in Healthy Participants |
|
|
Interventional
|
Phase 1 |
- Cascadian Therapeutics Inc.
- Seattle Genetics, Inc.
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Area under the concentration-time curve (AUC) from time 0 to infinity (AUC[0-inf])
- AUC from time 0 to last quantifiable concentration
- Maximum observed concentration
- (and 18 more...)
|
8 |
All |
18 Years to 65 Years (Adult, Older Adult) |
NCT03758339 |
ONT-380-008 |
|
December 30, 2017 |
January 30, 2018 |
January 30, 2018 |
November 29, 2018 |
November 29, 2018 |
|
- Covance Clinical Research Unit
Madison, Wisconsin, United States
|
|
| 69 |
NCT03748628 |
Completed |
Absorption, Metabolism and Excretion (AME) Study of [14C]EDP-305 in Healthy Male Subjects |
- NASH - Nonalcoholic Steatohepatitis
|
|
Interventional
|
Phase 1 |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Cmax of EDP-305 in plasma
- AUC of EDP-305 in plasma
- AUC-inf in plasma
- (and 3 more...)
|
8 |
Male |
18 Years to 55 Years (Adult) |
NCT03748628 |
EDP 305-009 |
|
October 5, 2018 |
October 13, 2018 |
October 13, 2018 |
November 21, 2018 |
November 21, 2018 |
|
- Covance Clinical Research Unit
Madison, Wisconsin, United States
|
|
| 70 |
NCT03744910 |
Recruiting |
Interleukin 6 Blockade Modifying Antibody-Mediated Graft Injury and Estimated Glomerular Filtration Rate (eGFR) Decline |
- Antibody-mediated Rejection
|
- Biological: Clazakizumab
- Drug: Normal saline
|
Interventional
|
Phase 3 |
- Vitaeris INC
- ICON Clinical Research
|
Industry |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Incidence of all cause composite allograft loss
|
350 |
All |
18 Years to 70 Years (Adult, Older Adult) |
NCT03744910 |
VKTX01 |
IMAGINE |
June 2019 |
January 2028 |
April 2028 |
November 19, 2018 |
June 12, 2019 |
|
- University of Wisconsin School of Medicine and Public Health (UWSMPH)
Madison, Wisconsin, United States
|
|
| 71 |
NCT03744169 |
Recruiting |
Use of Lung Ultrasound to Diagnose the Etiology of Respiratory Failure in a PICU. |
- Pediatric Respiratory Diseases
- Respiratory Failure
|
- Diagnostic Test: Lung ultrasound
- Diagnostic Test: Clinical exam
- Diagnostic Test: Chest x-ray
|
Observational
|
|
- University of Wisconsin, Madison
|
Other |
- Observational Model: Case-Only
- Time Perspective: Prospective
|
- Sensitivity and specificity of point-of-care lung ultrasound examination in identifying the etiology of acute pediatric respiratory failure on admission to the PICU.
- Determine the inter-observer reliability of point-of-care lung ultrasound examination findings in acute pediatric respiratory failure among trainee and expert sonographers.
|
100 |
All |
up to 18 Years (Child, Adult) |
NCT03744169 |
2018-0711 |
|
December 1, 2018 |
December 1, 2019 |
December 1, 2020 |
November 16, 2018 |
January 4, 2019 |
|
- University of Wisconsin, American Family Children's Hospital
Madison, Wisconsin, United States
|
|
| 72 |
NCT03739983 |
Not yet recruiting |
Alterations in the Vaginal Microenvironment Using a Non-pharmacological Intervention |
|
- Device: Vaginal Renewal Program
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
- American Cancer Society, Inc.
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Percentage of Superficial Vaginal Cells
- Change in Vaginal pH
- Patient Reported Outcomes: Number of Subjects with Improved Anxiety
- (and 4 more...)
|
25 |
Female |
18 Years and older (Adult, Older Adult) |
NCT03739983 |
UW17032
2018-0633
P30CA014520 |
|
June 2019 |
June 2020 |
June 2020 |
November 14, 2018 |
May 17, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 73 |
NCT03738579 |
Recruiting |
Assessment of the Improvement of Wound Healing Rate and Wound Bioburden With the Combination of Next Science Wound Gel and Wash |
|
- Device: Next Science Group
- Device: Control Group
- Device: Antibacterial Control Group
|
Interventional
|
Not Applicable |
- Next Science TM
- Advancing the Zenith of Healthcare
|
Industry / Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Wound Size and Volume
- Wound Closure
- Colony Forming Units
- (and 2 more...)
|
15 |
All |
18 Years and older (Adult, Older Adult) |
NCT03738579 |
CSP-009 |
|
October 17, 2018 |
October 2019 |
October 2019 |
November 12, 2018 |
March 13, 2019 |
|
- Advancing the Zenith of Healthcare
Milwaukee, Wisconsin, United States
|
|
| 74 |
NCT03733119 |
Recruiting |
ONC201 With and Without Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer |
- Triple Negative Breast Cancer
|
- Drug: Akt/ERK Inhibitor ONC201
- Dietary Supplement: Methionine-Restricted Diet
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
- National Cancer Institute (NCI)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Overall Response Rate (ORR)
- Progression-free survival (PFS)
- Overall Survival (OS)
- (and 3 more...)
|
112 |
Female |
18 Years to 64 Years (Adult) |
NCT03733119 |
UW17107
2018-0252
P30CA014520 |
|
November 13, 2018 |
April 1, 2021 |
October 1, 2021 |
November 7, 2018 |
February 27, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 75 |
NCT03722953 |
Recruiting |
Cerebrovascular Response to Acute Exercise |
|
- Other: Control
- Other: Aerobic Exercise
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- Cerebrovascular function
- Peripheral vascular function
|
20 |
All |
20 Years to 40 Years (Adult) |
NCT03722953 |
2018-0783 |
|
December 1, 2018 |
September 2019 |
December 2019 |
October 29, 2018 |
January 3, 2019 |
|
- Gymnasium-Natatorium
Madison, Wisconsin, United States
|
|
| 76 |
NCT03722030 |
Recruiting |
Telehealth-Based Resistance Training Intervention for Endometrial Cancer Survivors |
|
- Other: Baseline Measures
- Behavioral: Strength-Training
- Other: Mid-point Measures
- Other: Post-Study Measures
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- National Cancer Institute (NCI)
- American Cancer Society, Inc.
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Feasibility - Recruitment
- Feasibility - Adherence
- Safety - Total Adverse Events
- (and 12 more...)
|
20 |
Female |
18 Years to 74 Years (Adult, Older Adult) |
NCT03722030 |
UW18013
P30CA014520
NCI-2018-02257
2018-0953 |
|
September 27, 2018 |
October 1, 2019 |
October 1, 2019 |
October 26, 2018 |
October 26, 2018 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 77 |
NCT03710577 |
Completed |
Endocannabinoid and Psychological Responses to Yoga in Healthy Adults |
|
- Behavioral: Yoga
- Behavioral: Quiet Rest
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Plasma concentration of N-arachidonoylethanolamine
- Plasma concentration of 2-Arachidonoylglycerol (2-AG)
- Total Mood Disturbance (Profile of Mood States)
- (and 2 more...)
|
12 |
Female |
18 Years to 45 Years (Adult) |
NCT03710577 |
2017-0980 |
|
December 12, 2017 |
May 16, 2018 |
May 16, 2018 |
October 18, 2018 |
October 18, 2018 |
|
- University of Wisconsin-Madison Natatorium
Madison, Wisconsin, United States
|
|
| 78 |
NCT03708588 |
Recruiting |
Chewed Versus Integral Pill of Ticagrelor |
- Percutaneous Coronary Intervention
|
|
Interventional
|
Phase 4 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Concentration of pharmacodynamics
- Number of Participants with Major adverse cardiac and cerebrovascular event MACCE
|
130 |
All |
18 Years to 89 Years (Adult, Older Adult) |
NCT03708588 |
18-078_18-911 |
|
September 19, 2018 |
December 31, 2019 |
July 31, 2020 |
October 17, 2018 |
April 12, 2019 |
|
- Aurora Health Care, St. Luke's Medical Center
Milwaukee, Wisconsin, United States
|
|
| 79 |
NCT03704922 |
Recruiting |
Age of Blood in Sickle Cell Transfusion |
|
|
Interventional
|
Phase 2
Phase 3 |
- Blood Center of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
|
- Proportion of biochemically old red cell units
|
40 |
All |
18 Years to 45 Years (Adult) |
NCT03704922 |
00026112 |
|
October 1, 2018 |
March 30, 2021 |
March 30, 2021 |
October 15, 2018 |
October 17, 2018 |
|
- BloodCenter of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 80 |
NCT03704662 |
Recruiting |
Stereotactic Body Radiation Therapy or Conventionally Fractionated Concurrent Chemotherapy and Radiation Therapy Preoperatively for Resectable or Borderline Resectable Pancreatic Adenocarcinoma |
|
- Radiation: Stereotactic Body Radiation Therapy
- Radiation: Preoperative Fractionated Radiation Therapy and Chemotherapy
|
Interventional
|
Phase 2 |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Percentage of patients with node-positive disease following surgical resection comparison of conventially fractionated chemo RT versus SBRT.
- Compare patient-reported quality of life, as measured by the pancreatic cancer-specific QLQ PAN26 questionnaire.
- Overall survival.
- (and 3 more...)
|
102 |
All |
18 Years and older (Adult, Older Adult) |
NCT03704662 |
PRO33061 |
|
October 22, 2018 |
December 1, 2021 |
December 1, 2023 |
October 15, 2018 |
April 19, 2019 |
|
- Froedtert Hospital & Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 81 |
NCT03703505 |
Completed |
A Study to Evaluate the Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability of AG-348 in Healthy Male Participants Following Administration of a Single Oral Dose of [14C]AG-348 and Concomitant Single Intravenous Microdose of [13C6]AG-348 |
|
- Drug: AG-348
- Drug: [13C6]AG-348
|
Interventional
|
Phase 1 |
- Agios Pharmaceuticals, Inc.
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Basic Science
|
- AG-348 Excreted Through Urine [A(eu)]
- AG-348 Excreted through Feces [A(ef)]
- Total Amount Excreted Through Urine [Cumulative A(eu)] of AG-348
- (and 20 more...)
|
8 |
Male |
18 Years to 55 Years (Adult) |
NCT03703505 |
AG348-C-009 |
|
May 24, 2018 |
June 1, 2018 |
June 4, 2018 |
October 12, 2018 |
October 12, 2018 |
|
- Covance
Madison, Wisconsin, United States
|
|
| 82 |
NCT03703492 |
Recruiting |
Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS |
- Breast Cancer
- Ductal Carcinoma in Situ - Category
|
- Drug: (18F)FES
- Drug: Gadobenate dimeglumine
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
- National Cancer Institute (NCI)
|
Other / NIH |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- 18F-FES uptake in DCIS
- ER immunohistochemistry score
- Correlation of 18F-FES uptake in DCIS to ER immunohistochemistry score
- (and 7 more...)
|
34 |
Female |
18 Years and older (Adult, Older Adult) |
NCT03703492 |
UW18063
P30CA014520
NCI-2018-02281
2018-0814 |
|
November 12, 2018 |
December 31, 2021 |
December 31, 2021 |
October 12, 2018 |
January 17, 2019 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 83 |
NCT03699631 |
Recruiting |
PROACTIVE: Prevention of Acute and Chronic GVHD Using TocIlizumab in Combination With Standard GVHD Prophylaxis After allogEneic Transplantation |
|
- Drug: Tacrolimus
- Drug: Methotrexate
- Drug: Tocilizumab
|
Interventional
|
Phase 2 |
- Medical College of Wisconsin
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- GVHD-free/relapse-free survival (GRFS)
|
32 |
All |
18 Years and older (Adult, Older Adult) |
NCT03699631 |
PRO32694 |
|
November 6, 2018 |
April 1, 2020 |
April 1, 2021 |
October 8, 2018 |
March 6, 2019 |
|
- Froedtert Hospital
Milwaukee, Wisconsin, United States
|
|
| 84 |
NCT03696953 |
Recruiting |
The Efficacy of Probiotics to Reduce Antepartum Group B Streptococcus Colonization. |
- Group B Streptococcus Carrier in Childbirth
- Gastrointestinal Symptoms
|
|
Interventional
|
Phase 2 |
- Marquette University
- Aurora Health Care
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: Triple (Participant, Care Provider, Investigator)
- Primary Purpose: Prevention
|
- Proportion of participants with positive qualitative GBS culture
- GBS quantitive colony counts in colony forming units (CFU)
- Gastrointestinal (GI) symptom score
|
116 |
Female |
18 Years and older (Adult, Older Adult) |
NCT03696953 |
1R21HD095320-01 |
|
February 1, 2019 |
June 30, 2020 |
June 30, 2020 |
October 5, 2018 |
May 17, 2019 |
|
- Aurora Sinai Medical Center
Milwaukee, Wisconsin, United States
|
|
| 85 |
NCT03696758 |
Recruiting |
Improving Right Ventricular Function in Young Adults Born Preterm |
|
- Procedure: Pulmonary Function Testing
- Procedure: Electrocardiogram
- Procedure: Cardiac Magnetic Resonance Imaging
- (and 2 more...)
|
Interventional
|
Phase 2 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Right ventricular energetic efficiency
- left ventricular energetic efficiency
|
10 |
All |
18 Years to 35 Years (Adult) |
NCT03696758 |
2018-0796 |
|
October 30, 2018 |
September 2020 |
September 2020 |
October 5, 2018 |
December 28, 2018 |
|
- University of Wisconsin-Madison School of Medicine and Public Health
Madison, Wisconsin, United States
|
|
| 86 |
NCT03696043 |
Recruiting |
External Ventricular Drain Placement Stealth Study |
- External Ventricular Drain
- Intracranial Pressure
|
- Other: Axium Steatlh Image Guidance
- Other: EVD placement
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Treatment
|
- Number of catheter passes or attempts
- Accuracy of catheter tip compared to foramen of Monro
- Occurrence of post-placement hemorrhage
- (and 4 more...)
|
100 |
All |
18 Years to 88 Years (Adult, Older Adult) |
NCT03696043 |
2017-1487 |
|
August 15, 2018 |
December 31, 2020 |
December 31, 2020 |
October 4, 2018 |
January 8, 2019 |
|
- University of Wisconsin-Madison
Madison, Wisconsin, United States
|
|
| 87 |
NCT03694262 |
Not yet recruiting |
The EndoBARR Trial (Endometrial Bevacizumab, Atezolizumab, Rucaparib) |
|
- Drug: Rucaparib
- Drug: Bevacizumab
- Drug: Atezolizumab
|
Interventional
|
Phase 2 |
- Medical College of Wisconsin
- Genentech, Inc.
- Clovis Oncology, Inc.
|
Other / Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Overall Response Rate
- Progression Free Survival
- Number of participants with treatment-related adverse events as assessed by CTCAE V5.0
- Overall Survival
|
30 |
Female |
18 Years and older (Adult, Older Adult) |
NCT03694262 |
PRO |
EndoBARR |
June 15, 2019 |
June 28, 2021 |
June 28, 2026 |
October 3, 2018 |
May 24, 2019 |
|
- Froedtert Lutheran Memorial Hospital
Milwaukee, Wisconsin, United States
|
|
| 88 |
NCT03691766 |
Recruiting |
Photobiomodulation Therapy in Persons With Multiple Sclerosis |
- Multiple Sclerosis, Relapsing-Remitting
|
- Other: Photobiomodulation Therapy
- Other: Placebo
|
Interventional
|
Not Applicable |
- Marquette University
- University of Wisconsin, Milwaukee
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Triple (Participant, Investigator, Outcomes Assessor)
- Primary Purpose: Supportive Care
|
- Muscle Fatigue
- Systemic Inflammation
|
30 |
All |
20 Years to 60 Years (Adult) |
NCT03691766 |
HR-1710020115 |
|
April 30, 2018 |
April 29, 2019 |
August 31, 2019 |
October 2, 2018 |
October 2, 2018 |
|
- Marquette University
Milwaukee, Wisconsin, United States
|
|
| 89 |
NCT03685461 |
Recruiting |
AB-Intra- and Post-Operative Measures of Auditory Function |
- Hearing Loss
- Cochlear Implant
|
- Other: Electrocochleography
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Outcomes Assessor)
- Primary Purpose: Other
|
- The CI electrode's scalar position as indicated by post-operative computed tomography (CT)
- Post-operative hearing performance
|
192 |
All |
1 Year and older (Child, Adult, Older Adult) |
NCT03685461 |
PRO00032101 |
AB-ECOG |
September 11, 2018 |
August 31, 2023 |
August 31, 2024 |
September 26, 2018 |
September 26, 2018 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 90 |
NCT03682094 |
Recruiting |
Impact of Probiotics on Oral Microbiota in Older Adults With Dysphagia |
|
|
Interventional
|
Early Phase 1 |
- University of Wisconsin, Madison
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in Oral microbiota profiles- bacterial diversity
- Eating Assessment Test (EAT-10)
- Functional Oral Intake Scale (FOIS) Score
- (and 4 more...)
|
20 |
All |
65 Years to 99 Years (Older Adult) |
NCT03682094 |
2018-0428 |
|
August 13, 2018 |
August 31, 2019 |
August 31, 2019 |
September 24, 2018 |
September 24, 2018 |
|
- University of Wisconsin-Madison
Madison, Wisconsin, United States
|
|
| 91 |
NCT03682081 |
Not yet recruiting |
Interventions for Patients With Alzheimer's Disease and Dysphagia |
|
- Device: Isometric tongue strengthening
- Drug: Biotene
|
Interventional
|
Early Phase 1 |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Change in Lingual Pressures at the Anterior and Posterior Tongue Locations
- Change in Perceived Swallow Effort
- Change in Penetration-Aspiration Scale scores
- (and 6 more...)
|
76 |
All |
18 Years to 99 Years (Adult, Older Adult) |
NCT03682081 |
2018-0835 |
|
July 1, 2019 |
February 1, 2023 |
February 1, 2023 |
September 24, 2018 |
June 14, 2019 |
|
- University of Wisconsin-Madison
Madison, Wisconsin, United States
|
|
| 92 |
NCT03675321 |
Recruiting |
Defining Adolescent Nausea Through Brain Imaging and Neurostimulation Response |
- Functional Gastrointestinal Disorders
|
- Device: Active Auricular Neurostimulation
- Device: Sham Auricular Neurostimulation
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
- National Institutes of Health (NIH)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Nausea Severity Scale
- Nausea Profile
- Baxter Retching Faces scale
|
110 |
All |
11 Years to 18 Years (Child, Adult) |
NCT03675321 |
1064187-2 |
|
April 23, 2018 |
June 2022 |
September 2022 |
September 18, 2018 |
September 18, 2018 |
|
- Children's Hospital of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 93 |
NCT03675009 |
Completed |
Milwaukee Day Cares Indoor Air Quality Assessment and Educational Response Study |
|
- Other: Educational Programming
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
- University of Wisconsin, Milwaukee
|
Other |
- Allocation: Randomized
- Intervention Model: Sequential Assignment
- Masking: Double (Participant, Care Provider)
- Primary Purpose: Health Services Research
|
- Alterations in total Volatile Organic Compounds (tVOC) temporally associated with the educational intervention
- Alterations in particulate matter (PM2.5) temporally associated with the educational intervention
- Assessment of Cleaning Practices (including VOC generation) practice changes associated with the Educational Intervention
- (and 4 more...)
|
30 |
All |
18 Years and older (Adult, Older Adult) |
NCT03675009 |
5520466 |
|
April 1, 2018 |
March 31, 2019 |
April 19, 2019 |
September 18, 2018 |
April 22, 2019 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 94 |
NCT03674528 |
Recruiting |
Technical Validation of MR Biomarkers of Obesity-Associated NAFLD |
- Non-Alcoholic Fatty Liver Disease
- Non-alcoholic Steatohepatitis
|
- Other: Magnetic Resonance Elastography (MRE)
- Diagnostic Test: Liver biopsy
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
|
Other / NIH |
- Allocation: Non-Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Diagnostic
|
- Optimization of MRE for 2 dimensional and 3 dimensional methods
|
145 |
All |
18 Years and older (Adult, Older Adult) |
NCT03674528 |
2018-0244
2R01DK088925-06A1 |
NAFLD |
May 4, 2018 |
May 1, 2021 |
May 1, 2023 |
September 17, 2018 |
January 24, 2019 |
|
- University of Wisconsin, Madison
Madison, Wisconsin, United States
|
|
| 95 |
NCT03656679 |
Recruiting |
Paravertebral Versus Pectoralis Block for Post Mastectomy Pain |
- Pain, Postoperative
- Post-Mastectomy Chronic Pain Syndrome
- Opioid Use
|
- Procedure: Pectoralis Blockade (PECs)
- Procedure: Paravertebral Blockade
|
Interventional
|
Not Applicable |
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Total Opioid Consumption
- time to perform the block
- Pain score
- (and 7 more...)
|
90 |
Female |
18 Years to 80 Years (Adult, Older Adult) |
NCT03656679 |
2018-0579
NCI-2018-01743
UW17141 |
|
October 18, 2018 |
October 1, 2020 |
December 1, 2021 |
September 3, 2018 |
November 5, 2018 |
|
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
|
|
| 96 |
NCT03656276 |
Recruiting |
The "ToPIC" Study = Tool to Improve Participation In Clinical Trials |
- Communication
- Physician-Patient Relations
|
- Behavioral: Tool to improve Participation In Clinical Trials (ToPIC)
|
Observational
|
|
- University of Wisconsin, Madison
- National Cancer Institute (NCI)
- University of Wisconsin Institute for Clinical and Translational Research
|
Other / NIH |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Number of patients that consent to a therapeutic trial.
- Number of oncologists that can learn the ToPIC tool after 3 hours of training.
- Number of patients that enroll in a therapeutic trial.
- Number of patients that agree to hear about therapeutic trial.
|
80 |
All |
19 Years and older (Adult, Older Adult) |
NCT03656276 |
UW16060
P30CA014520
2016-1579 |
|
March 10, 2017 |
July 2019 |
July 2019 |
September 3, 2018 |
September 3, 2018 |
|
- University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
|
|
| 97 |
NCT03648918 |
Recruiting |
Genetics Of Autoimmunity In Type I Diabetes |
- Type1diabetes
- Diabetes Mellitus, Type 1
- Type1 Diabetes Mellitus
- Diabetes Mellitus
|
|
Observational
|
|
- Medical College of Wisconsin
- Benaroya Research Institute
- Indiana University
|
Other |
- Observational Model: Family-Based
- Time Perspective: Prospective
|
- Onset of Type 1 diabetes
- Autoantibody Measurement
|
4000 |
All |
2 Years and older (Child, Adult, Older Adult) |
NCT03648918 |
142618
McGee Family Study |
|
August 2001 |
January 2050 |
January 2050 |
August 28, 2018 |
August 28, 2018 |
|
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
|
|
| 98 |
NCT03641989 |
Suspended |
Correlation Between Oral Health and Systemic Inflammation (COHESION) |
- Inflammation
- Periodontal Disease
- Gingivitis
|
- Other: Plaque disclosing toothpaste
- Other: Non-plaque disclosing toothpaste
|
Interventional
|
Not Applicable |
- Marshfield Clinic Research Foundation
- University of Wisconsin, Madison
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Single (Participant)
- Primary Purpose: Prevention
|
- Change in hsCRP levels with the use of the assigned toothpaste.
- Bleeding on Probing (BOP
- Periodontal Pocket Depth (PPD)
- (and 3 more...)
|
132 |
All |
21 Years to 84 Years (Adult, Older Adult) |
NCT03641989 |
ACH10317 |
COHESION |
September 17, 2018 |
June 2019 |
July 2019 |
August 22, 2018 |
June 11, 2019 |
|
- Marshfield Clinic-Marshfield Center
Marshfield, Wisconsin, United States
|
|
| 99 |
NCT03641573 |
Completed |
Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male Subjects |
|
|
Interventional
|
Phase 1 |
|
Industry |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Cmax - maximum observed plasma concentration (plasma and whole blood)
- tmax - time at which Cmax occurs (plasma and whole blood)
- AUC0 t - area under the plasma concentration time curve from time zero to the last measurable concentration (plasma and whole blood)
- (and 7 more...)
|
8 |
Male |
20 Years to 60 Years (Adult) |
NCT03641573 |
ASN002AD-102 |
|
October 11, 2018 |
October 21, 2018 |
October 21, 2018 |
August 22, 2018 |
November 1, 2018 |
|
- Covance Clinical Research Unit
Madison, Wisconsin, United States
|
|
| 100 |
NCT03630965 |
Recruiting |
CPR Audiovisual Tool to Impact ICU Patients' Surrogate Anxiety Level. |
|
|
Interventional
|
Not Applicable |
- Medical College of Wisconsin
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Other
|
- Measure the impact of CPR video on the Surrogate's level of anxiety during the decision-making process on code status, in the ICU compared to the control group of surrogates (No intervention group).
- Measure the impact of CPR video on patients' surrogate's knowledge about CPR, when compared to the No intervention group.
- Analyze the surrogates' comfort when watching the video.
- Describe if the CPR video's impact on surrogates' anxiety level, is affected by the patient's severity of illness as per the SOFA score.
|
30 |
All |
18 Years to 100 Years (Adult, Older Adult) |
NCT03630965 |
PULM-AV-CPR
PRO00029203 |
|
May 8, 2017 |
December 31, 2019 |
May 30, 2020 |
August 15, 2018 |
August 16, 2018 |
|
- Medical College of Wisconsin/Froedtert Hospital
Milwaukee, Wisconsin, United States
|
|
Create an RSS feed from your search for:
Download the search results for: